NCT02294747

Brief Summary

Trochanteric fractures represent about half of the hip fractures (with femoral neck fractures as the other half). Trochanteric hip fractures are almost always treated surgically with internal fixation of the fracture. However there is a debate ongoing for what is the appropriate implant to use. For stable fracture patterns the evidence seems to be in favor of the sliding hip screw, but for the unstable fractures it is more unclear whether to use a intramedullary nail or sliding hip screw with or without a lateral support plate (TSP). The role of the TSP in clinical use remains unclear and very little has been published about this, but it is believed to be an important contributor of stability to the sliding hip screw construct. We are planning a randomized controlled trial on trochanteric hip fractures to establish a method for implanting the tantalum markers, to observe the fracture healing process and to further investigate the role of the TSP.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
31

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2014

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2014

Completed
11 days until next milestone

First Submitted

Initial submission to the registry

November 12, 2014

Completed
7 days until next milestone

First Posted

Study publicly available on registry

November 19, 2014

Completed
4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2018

Completed
Last Updated

September 29, 2020

Status Verified

September 1, 2020

Enrollment Period

4.1 years

First QC Date

November 12, 2014

Last Update Submit

September 26, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Fracture displacement during healing measured with radiostereometry

    Will be measured by RSA postoperatively, before discharge and after 4, 8, 12, 24 and 52 weeks. Total displacement from first reading to the reading showing maximum displacement is the main outcome.

    52 weeks

Secondary Outcomes (32)

  • Perioperative blood loss

    1 week

  • Time of surgery

    1 week

  • Eq5d

    52 weeks

  • Eq5d

    26 weeks

  • Eq5d

    12 weeks

  • +27 more secondary outcomes

Other Outcomes (2)

  • Reoperation for healing problems

    52 weeks

  • Mortality

    52 weeks

Study Arms (2)

SHS without TSP

ACTIVE COMPARATOR

Patients with AO 31 A2 trochanteric fractures operated with sliding hip screw without trochanteric stabilization plate.

Device: Sliding Hip Screw without Trochanteric Stabilization Plate

SHS with TSP

ACTIVE COMPARATOR

Patients with AO 31 A2 trochanteric fractures operated with sliding hip screw with trochanteric stabilization plate.

Device: Sliding Hip Screw with Trochanteric Stabilization Plate

Interventions

Also known as: Lateral Stabilizing Plate, Lateral Support Shield
SHS with TSP

Eligibility Criteria

Age50 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • AO 31-A2
  • able to walk independently, aids such as crutches or walker allowed
  • able to consent
  • fit for surgery with SHS with or without TSP

You may not qualify if:

  • not willing or able to attain follow up
  • previous fracture or surgery with retained metal work in the same hip
  • concomitant disease that will shorten life expectancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Orthopedic Center, Ulleval University Hospital

Oslo, 0408, Norway

Location

Diakonhjemmet Hospital

Oslo, Norway

Location

MeSH Terms

Conditions

Hip Fractures

Condition Hierarchy (Ancestors)

Femoral FracturesFractures, BoneWounds and InjuriesHip InjuriesLeg Injuries

Study Officials

  • Frede Frihagen, PhD

    Oslo University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Consultant, PhD

Study Record Dates

First Submitted

November 12, 2014

First Posted

November 19, 2014

Study Start

November 1, 2014

Primary Completion

December 1, 2018

Study Completion

December 1, 2018

Last Updated

September 29, 2020

Record last verified: 2020-09

Locations